• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Catalent - Articles and news items

Catalent

Catalent & Sanofi to collaborate on SMARTag™ antibody-drug conjugate technology with Sanofi’s proprietary antibodies

Industry news / 16 January 2015 / Catalent

Catalent Pharma Solutions has entered into a collaboration with Sanofi-Aventis Recherche & Développement, a Sanofi Company to implement Catalent’s proprietary SMARTag™ technology in the development of next generation Antibody-Drug Conjugates…

Paul Wituschek, Catalent

Antibody Drug Conjugates (ADC)

Supplier news / 19 February 2014 / Paul Wituschek, Vice President of Sales, Development and Clinical Services, Catalent

Paul Wituschek, Vice President of Sales, Development and Clinical Services, Catalent answers the question: “Other than oncology, for which disease areas do you see Antibody Drug Conjugates (ADC) being used extensively in the future?”

Dr David Igo, Director of Product Development and Manufacturing at Catalent

Catalent presents at AAPS 2013

News, Supplier news, Videos / 22 November 2013 / Freddy White, European Pharmaceutical Review

Dr David Igo, Director of Product Development and Manufacturing at Catalent, presents their new FormProRx™ Web Tool to Freddy White at AAPS 2013.

Irena McGuffy, Manager, Softgel Formulation at Catalent

Catalent presents at AAPS 2013

News, Supplier news, Videos / 18 November 2013 / Freddy White, European Pharmaceutical Review

Irena McGuffy, Manager, Softgel Formulation at Catalent presents to Freddy White at AAPS 2013…

Catalent

Catalent appoints first President of Asia Pacific

News, Supplier news / 9 September 2013 / Catalent Pharma Solutions

Catalent Pharma Solutions has named David Heyens in the new role of President of Catalent Asia Pacific…

Catalent

Catalent and Biota Pharmaceuticals expand their alliance

News, Supplier news / 10 July 2013 / Catalent Pharma Solutions

Catalent Pharma Solutions has entered into a contract with Biota Pharmaceuticals, Inc…

Catalent
Catalent
Catalent

Catalent makes major investment to expand inhalation capabilities in Research Triangle Park, NC

News, Supplier news / 10 January 2013 / Catalent Pharma Solutions

The investment will focus on expanding pMDI clinical and commercial supply capabilities…

Catalent

Oral drug delivery for Macromolecules using softgel lipid delivery systems to be presented by Catalent expert

News, Supplier news / 28 November 2012 / Catalent Pharma Solutions

Jeffrey E. Browne at Catalent Pharma Solutions will be presenting…

Catalent

Catalent announces cell line sales agreement with CEVEC

News, Supplier news / 13 November 2012 / Catalent Pharma Solutions

Deal follows study which achieved record yield for human alpha-1 antitrypsin (hAAT) molecule…

Under the microscope: Graeme Lowe, Catalent

Issue 4 2012 / 3 September 2012 / Helen Bahia, Editor, European Pharmaceutical Review

Graeme Lowe, Director of Development and Analytical Solutions at Catalent, discusses outsourcing pharmaceutical development and analytical solutions.

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +